PHARMACIST

Main information

  • Trade name:
  • PHARMACIST FORMULA StomachEze hyoscine butylbromide 20mg tablet blister pack
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PHARMACIST FORMULA StomachEze hyoscine butylbromide 20mg tablet blister pack
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 218021
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

218021

PHARMACIST FORMULA StomachEze hyoscine butylbromide 20mg tablet blister pack

ARTG entry for

Medicine Registered

Sponsor

Pharmacare Laboratories Pty Ltd

Postal Address

PO Box 384,MONA VALE, NSW, 1660

Australia

ARTG Start Date

3/12/2013

Product category

Medicine

Status

Active

Approval area

Non-Prescription Medicines

Conditions

Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods

Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered

or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Products

1. PHARMACIST FORMULA StomachEze hyoscine butylbromide 20mg tablet blister pack

Product Type

Single Medicine Product

Effective date

3/12/2013

Warnings

No Warnings included on Record

Standard Indications

Specific Indications

Spasm of the gastrointestinal tract

Additional Product information

Container information

Type

Material

Life Time

Temperature

Closure

Conditions

Blister Pack

PVC/PE/PVDC/Al

24 Months

Store below 30

degrees Celsius

Neither child resistant

closure nor restricted

flow insert

Not recorded

Pack Size/Poison information

Pack Size

Poison Schedule

(S2) Pharmacy Medicine

Components

1.

Dosage Form

Tablet, film coated

Route of Administration

Oral

Visual Identification

off white, round, biconvex, film coated, plain on both side

Active Ingredients

Hyoscine butylbromide

20 mg

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 26.11.2017 at 05:39:41 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

18-10-2018

October 18, 2018: Pharmacist Indicted for Taking Drugs, Carrying Firearm in Violation of Court Order

October 18, 2018: Pharmacist Indicted for Taking Drugs, Carrying Firearm in Violation of Court Order

October 18, 2018: Pharmacist Indicted for Taking Drugs, Carrying Firearm in Violation of Court Order

FDA - U.S. Food and Drug Administration

17-9-2018

September 11, 2018: Columbus Pharmacist Sentenced for Health Care Fraud Scheme

September 11, 2018: Columbus Pharmacist Sentenced for Health Care Fraud Scheme

September 11, 2018: Columbus Pharmacist Sentenced for Health Care Fraud Scheme

FDA - U.S. Food and Drug Administration

23-8-2018

August 22, 2018: Louisiana Pharmacist Convicted of Trafficking and Selling Stolen Medication

August 22, 2018: Louisiana Pharmacist Convicted of Trafficking and Selling Stolen Medication

August 22, 2018: Louisiana Pharmacist Convicted of Trafficking and Selling Stolen Medication

FDA - U.S. Food and Drug Administration

10-5-2018

May 10, 2018: Former New Hampshire Pharmacist Sentenced to Two Years in Prison for Drug-Related Offenses

May 10, 2018: Former New Hampshire Pharmacist Sentenced to Two Years in Prison for Drug-Related Offenses

May 10, 2018: Former New Hampshire Pharmacist Sentenced to Two Years in Prison for Drug-Related Offenses

FDA - U.S. Food and Drug Administration

30-8-2018

Consultation: Referral of proposed amendment to the current Poisons Standard to the meeting of the ACMS, March 2019

Consultation: Referral of proposed amendment to the current Poisons Standard to the meeting of the ACMS, March 2019

Advisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'. Closing date 31 October 2018

Therapeutic Goods Administration - Australia

30-8-2018

Modified release paracetamol

Modified release paracetamol

Advisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'

Therapeutic Goods Administration - Australia